NCBiotech News

Scientists say treating allergies in people provides insight into ways to treat animals with similar problems.

Plant Response, a Spanish agricultural biologicals company with North American headquarters in Durham, has acquired Pathway BioLogic of Plant City, Fla

Global pharmaceutical giant Eli Lilly and Company will build its first North Carolina manufacturing facility in the Durham County portion of Research Triangle Park, investing $474 million and creating 462 new jobs.

Durham-based CoImmune, a cell therapy company acquired by two South Korean biotech firms last year, will continue to grow through a merger with another East Coast biotech firm.

Alexandria Launch Labs is offering a $100,000 prize that includes $75,000 in cash and a one-year membership at Alexandria Center for AgTech for one innovative startup.

The FDA has accepted the company’s Investigational New Drug (IND) application and also granted the therapy Orphan Drug Designation, a status that gives companies tax reductions and other incentives to develop treatments for rare diseases.

Burlington-based LabCorp has introduced a suite of cell and gene therapy development services from Covance, its drug development business, to help biopharmaceutical companies develop cell and gene therapies for cancer and other diseases.

Researchers at the University of North Carolina at Chapel Hill are one step closer to a possible new treatment against multiple myeloma, a devastating type of blood cancer.

Bryn Pharma, a privately held Raleigh medical device company, is on track to soon provide people who have severe, possibly life-threatening allergies a needle-free option to treat anaphylaxis.

A hand-held fluid resuscitation device developed by Durham start-up 410 Medical has been generating major buzz and billings for its unique design and potential to improve patient care.

Duke University School of Nursing is teaming up with NCBiotech to host a new Healthcare Innovation Conference on February 21 to encourage nurses and other healthcare workers to turn their ideas Into solutions.

Morrisville-based Locus Biosciences, a developer of precision antibacterial therapies, will conduct the world’s first clinical trial of a recombinant bacteriophage therapy, a major milestone for the field, the company announced.

A workshop to be held in Research Triangle Park on Feb. 12 will help set pest management priorities for the fledging sorghum industry in North Carolina and surrounding states.

Duke University has teamed up with Deerfield Management, a New York-based health care investment firm, to form a drug spin-out company called Four Points Innovation.

AgBiome, an agricultural technology firm that harnesses plant microbiomes to develop novel crop protection products, is teaming up with a French ag tech company to develop biotech corn traits resistant to the most common species of insect pests in maize.